Results 131 to 140 of about 44,265 (336)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Execution Integrity with In-Place Encryption

, 2017
Instruction set randomization (ISR) was initially proposed with the main goal of countering code-injection attacks. However, ISR seems to have lost its appeal since code-injection attacks became less attractive because protection mechanisms such as data ...
Arias, Orlando, Davi, Lucas, Gens, David, Jin, Yier, Sadeghi, Ahmad-Reza, Sullivan, Dean   +5 more
core  

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Cryptanalytic Attacks on IDEA Block Cipher

, 2016
Harish Kumar Sahu, Vikas Jadhav, Shefali Sonavane, R. K. Sharma   +3 more
openalex   +1 more source

Efficient Recursive Diffusion Layers for Block Ciphers and Hash Functions [PDF]

, 2013
Mahdi Sajadieh, Mohammad Dakhilalian, Hamid Mala, Pouyan Sepehrdad   +3 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

A Review on Lightweight Block Ciphers

, 2020
Shilpa K, Chinchu A
openalex   +1 more source

Cryptanalysis of the Lightweight Block Cipher BORON [PDF]

, 2019
Huicong Liang, Meiqin Wang
openalex   +1 more source

GFRX: A New Lightweight Block Cipher for Resource-Constrained IoT Nodes [PDF]

, 2023
Xing Zhang, Shaoyu Tang, Tianning Li, Xiaowei Li, Changda Wang   +4 more
openalex   +1 more source